Switching Australian patients with moderate to severe inflammatory bowel disease from originator infliximab to biosimilar Inflectra: Interim results from a multicenter parallel cohort study
Craig Haifer(University of Sydney), Lena Thin(The University of Western Australia), Daniel R. van Langenberg(Eastern Health), Simon Ghaly(UNSW Sydney), Ashish Srinivasan(Eastern Health), Jakob Begun(Translational Research Institute), Sherman Picardo(Royal Perth Hospital), Yoon‐Kyo An(Mater Hospital), S. Menon
UWA Profiles and Research Repository (University of Western Australia)
January 1, 2019
Cited by 3
Related Papers
Deep Resequencing of GWAS Loci Identifies Rare Variants in CARD9, IL23R and RNF186 That Are Associated with Ulcerative Colitis
|PLoS Genetics|2013|217
Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis
|Inflammatory Bowel Diseases|2019|94
Adhesion formation after previous caesarean section-a meta-analysis and systematic review
|BJOG An International Journal of Obstetrics & Gynaecology|2010|73
Objectively measured muscle fatigue in Crohn's disease: Correlation with self-reported fatigue and associated factors for clinical application
|Journal of Crohn s and Colitis|2013|66